US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

668.63

-5.4946-0.81%

Number of Gainers:62

Number of Losers:81

Number of Flat:10

PE:- -

High:687.10

Open:668.22

Low:665.90

Close:674.17

Volume:153.32M

Turnover:7.39B

Market Cap:461.37B

Float Cap:360.49B

Loading ...

Analysts Offer Insights on Technology Companies: UiPath (PATH) and Fastly (FSLY)

Analysts Offer Insights on Technology Companies: UiPath (PATH) and Cognex (CGNX)

Travere Therapeutics receives notice of allowance for FILSPARI patent

Absci Price Target Maintained with a $11.00/Share by Needham

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress

Cardiol Therapeutics Expands Phase III MAVERIC Trial After Early Enrollment Milestone

Coinbase Spots Extreme Bullish Demand in XRP Options

Maze Therapeutics initiated with a Buy at Citi

Zip Co Appoints New Director Sarah Adam-Gedge With No Initial Shareholding

Fidelity International: Global Growth to Remain Resilient in 2H 2026, Raises US Reflation Probability to 60%

UiPath Inc : RBC Cuts Target Price to $15 from $17

THOMSON REUTERS

Prescient Therapeutics Raises Around AU$4.8 Million Via Share Purchase Plan, AU$1.2 Million in Shortfall Placement

MT Newswires Live

Top Executive Makes Significant Move in Structure Therapeutics Stock

Prescient Therapeutics Plans New Share Placement on ASX

ZipRecruiter CEO Ian H. Siegel Disposes of $201,694.47 in Common Shares

Press Release: Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release

Pop Culture Group Co., Ltd: Enters into Share Purchase Agreement to Sell 665,000 Class a Shares at $3.00 Per Share - SEC Filing

THOMSON REUTERS

Pop Culture Group Enters Registered Direct Offering for up to 665,000 Class a Shares at US$3 Each

Biomea Fusion Updates Timeline for BMF-650 Phase I Data

Biomea Fusion announces offering of common stock and warrants, no amount given

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4539/news?page=30"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":668.6711,"timestamp":1790963104024,"preClose":674.16565,"halted":0,"volume":153314337,"delay":0,"changeRate":-0.00815,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-5.494568,"latestTime":"10-02 13:45:04 EDT","open":668.2159,"high":687.09705,"low":665.8983,"amount":7392736684.600338,"amplitude":0.031444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790971200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.201059,"peRate":114.807925,"turnoverRate":0.012062,"increases":62,"decrements":81,"flats":7,"marketCap":461373154829.375,"floatMarketCap":360485129032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":687.09705,"amplitude":0.031444,"preClose":674.16565,"low":665.8983,"pbRate":"5.201059","latestPrice":668.6264,"volume":153318671,"delay":0,"open":668.2159,"prevYearClose":881.5255,"prevWeekClose":697.624,"prevMonthClose":677.2829,"prevQuarterClose":677.2829,"fiveDayClose":697.624,"twentyDayClose":733.4782,"sixtyDayClose":783.9062,"secType":"PLATE","market":"US","turnoverRate":0.012063,"peRate":114.807925,"marketCap":461335078677.375,"floatMarketCap":360453718992,"timestamp":1790963105525,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":62,"down":81,"flat":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:30,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669488240","title":"Analysts Offer Insights on Technology Companies: UiPath (PATH) and Fastly (FSLY)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488240","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488240?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:30","pubTimestamp":1790163026,"startTime":"0","endTime":"0","summary":"Analysts fell to the sidelines weighing in on UiPath (PATH) and Fastly (FSLY) with neutral ratings, indicating that the experts are neither bullish...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-uipath-path-and-fastly-fsly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-uipath-path-and-fastly-fsly-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1861558580.USD","BK4585","BK4505","BK4561","BK4547","LU1861559042.SGD","PATH","BK4588","BK4613","BK4097","BK4554","BK4608","PATX","BK4539","FSLY","BK4116","BK4604","BK4543","BK4551"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488339","title":"Analysts Offer Insights on Technology Companies: UiPath (PATH) and Cognex (CGNX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488339","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488339?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:11","pubTimestamp":1790161862,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Technology sector with new ratings on UiPath (PATH) and Cognex (CGNX). UiPath (PATH) RBC Capital analys...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-uipath-path-and-cognex-cgnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-technology-companies-uipath-path-and-cognex-cgnx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0708994859.HKD","BK4561","IE00BZ199S13.USD","LU0310800379.SGD","BK4505","TECS","BK4585","LU1861558580.USD","PATX","ARTY","BK4157","BK4207","BK4097","BK4543","BK4551","LU1861559042.SGD","LU0128525929.USD","RSHO","BK4588","PATH","CGNX","LU0029864427.USD","LU1267930573.SGD","BK4604","BK4547","GSIB","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669448832","title":"Travere Therapeutics receives notice of allowance for FILSPARI patent","url":"https://stock-news.laohu8.com/highlight/detail?id=2669448832","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669448832?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:10","pubTimestamp":1790161811,"startTime":"0","endTime":"0","summary":"Travere Therapeutics (TVTX) announced that the United States Patent and Trademark Office issued a Notice of Allowance for U.S. Patent Application N...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/travere-therapeutics-receives-notice-of-allowance-for-filspari-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/travere-therapeutics-receives-notice-of-allowance-for-filspari-patent-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FFTY","LENZ","TVTX","BK4139","BK4007","USRD","BK4539","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669910070","title":"Absci Price Target Maintained with a $11.00/Share by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2669910070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669910070?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:09","pubTimestamp":1790161740,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABSI/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ARKG","BK4121","ABSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669488488","title":"Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress","url":"https://stock-news.laohu8.com/highlight/detail?id=2669488488","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669488488?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161200,"startTime":"0","endTime":"0","summary":"WAYNE, Pa., Sept.  23, 2026 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics targeting the IL-1β pathway for imm","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/23/3367320/0/en/avalo-therapeutics-to-present-at-the-european-academy-of-dermatology-and-venereology-eadv-2026-congress.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EPV","BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100139","title":"Cardiol Therapeutics Expands Phase III MAVERIC Trial After Early Enrollment Milestone","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100139","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669100139?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:57","pubTimestamp":1790161057,"startTime":"0","endTime":"0","summary":"Cardiol Therapeutics ( ($TSE:CRDL) ) has shared an update. On September 23, 2026, Cardiol Therapeutics reported that it had reached the original 11...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-expands-phase-iii-maveric-trial-after-early-enrollment-milestone?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/cardiol-therapeutics-expands-phase-iii-maveric-trial-after-early-enrollment-milestone?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670149275","title":"Coinbase Spots Extreme Bullish Demand in XRP Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2670149275","media":"utoday","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670149275?lang=en_us&edition=fundamental","pubTime":"2026-09-23 18:57","pubTimestamp":1790161020,"startTime":"0","endTime":"0","summary":"XRP options traders are paying an unusually steep premium for upside exposure.Coinbase Markets has spotted one of the strongest bullish skews seen in the market over the past year.According to Coinbas","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"utodaynews_highlight","url":"https://u.today/coinbase-spots-extreme-bullish-demand-in-xrp-options","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://u.today/coinbase-spots-extreme-bullish-demand-in-xrp-options","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"utodaynews_highlight","symbols":["09711","XRPI","CRPT","BK4595","BK4600","LU1861558580.USD","BK4554","CONL","XRPR","09311","CONI","CONX","CONY","BITQ","BLCK","ICOI","COII","FINX","BK4596","IBLC","COIN","BK4112","COIA","LU1861220207.SGD","BK4585","COIX","07311","BK4535","07711","COIO","LU1861217088.USD","LU2360107671.USD","BK4516","XRP.USD.CC","XRPK","LU1861559042.SGD","COYY","BK4539","BK4551","COIG","FDIG","FIAT","BK4588","COIW","BKCH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669104282","title":"Maze Therapeutics initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2669104282","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669104282?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:20","pubTimestamp":1790155214,"startTime":"0","endTime":"0","summary":"Citi initiated coverage of Maze Therapeutics (MAZE) with a Buy rating and $50 price target The firm sees the company’s APOL1-mediated kidney diseas...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/maze-therapeutics-initiated-with-a-buy-at-citi-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4139","BK4007","MAZE","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669067571","title":"Zip Co Appoints New Director Sarah Adam-Gedge With No Initial Shareholding","url":"https://stock-news.laohu8.com/highlight/detail?id=2669067571","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669067571?lang=en_us&edition=fundamental","pubTime":"2026-09-23 16:17","pubTimestamp":1790151457,"startTime":"0","endTime":"0","summary":"An announcement from Zip Co Ltd. ( ($AU:ZIP) ) is now available. Zip Co Limited has announced the appointment of Sarah Adam-Gedge as a director, ef...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/zip-co-appoints-new-director-sarah-adam-gedge-with-no-initial-shareholding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/zip-co-appoints-new-director-sarah-adam-gedge-with-no-initial-shareholding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4077","BK4539","ZIP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138489921","title":"Fidelity International: Global Growth to Remain Resilient in 2H 2026, Raises US Reflation Probability to 60%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138489921","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138489921?lang=en_us&edition=fundamental","pubTime":"2026-09-23 13:54","pubTimestamp":1790142861,"startTime":"0","endTime":"0","summary":"Fidelity International’s macro team projects that global economic growth will stay broadly resilient in the second half of 2026, though momentum may ease slightly following a robust first half, with...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WSGE","EDGI","UNIY","RGLO","BK4526","LU0359201612.USD","LU0456842615.SGD","BK4548","IE00BYTNYN87.SGD","LU0572944931.SGD","IEF","ACWI","BK4503","LU0359201885.HKD","IGOV","BWZ","RULE","SHV","UCIB","LU1023057109.AUD","BBSB","RSEE","TLTX","LU2242644610.SGD","CWS","LU0502904849.HKD","YMM","IEI","BK4585","LU0048575426.USD","LU0049112450.USD","LU0261950470.USD","TLT","TSYW","BK4232","IE00B12V2V27.USD","BWX","LU1235295612.USD","LU2247934214.USD","BK4022","IE00BYQNZ168.SGD","LU0455707207.USD","FITZ","LU0327786744.USD","LU1046422090.SGD","TLTI","TLH","FLGV","TBJL","EDGF","BK4588","BSR","RMIF","SGOV","FLXI","BBLB","LU0359202008.SGD","SHY","BBIB","TLTW","AVGE","TFJL","TPLS","CRXP","ISHG","SG9999011746.SGD","BK4550","LU0251143458.SGD","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669717456","title":"UiPath Inc : RBC Cuts Target Price to $15 from $17","url":"https://stock-news.laohu8.com/highlight/detail?id=2669717456","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669717456?lang=en_us&edition=fundamental","pubTime":"2026-09-23 11:27","pubTimestamp":1790134064,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45E0UC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1861559042.SGD","BK4097","BK4539","BK4551","BK4547","BK4588","PATH","BK4604","BK4543","BK4585","PATX","BK4505","LU1861558580.USD","BK4561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179100","title":"Prescient Therapeutics Raises Around AU$4.8 Million Via Share Purchase Plan, AU$1.2 Million in Shortfall Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179100","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179100?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:15","pubTimestamp":1790129735,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics  raised around AU$4.8 million via its share purchase plan and around AU$1.2 million in the shortfall placement, according to a Wednesday Australian bourse filing.The issue price under the share purchase plan and the placement was AU$0.065 apiece. Around 18.5 million new shares are expected to be issued under the placement.The proceeds will provide additional funding for the continued development of its PTX-100 treatment candidate beyond the first dose optimization committee review.Its shares fell 2% in recent trading on Wednesday.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","PTX.AU","BK4139","BK7067","BK4539","LENZ","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669179288","title":"Top Executive Makes Significant Move in Structure Therapeutics Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2669179288","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669179288?lang=en_us&edition=fundamental","pubTime":"2026-09-23 10:04","pubTimestamp":1790129061,"startTime":"0","endTime":"0","summary":"New insider activity at Structure Therapeutics, Inc. Sponsored ADR ( ($GPCR) ) has taken place on September 22, 2026. Chief Medical Officer Blas Co...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-significant-move-in-structure-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-significant-move-in-structure-therapeutics-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CVY","BK4539","AADR","LENZ","ARMH","APIE","BK4007","BK4139","DIVL","DINT","SAPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669170175","title":"Prescient Therapeutics Plans New Share Placement on ASX","url":"https://stock-news.laohu8.com/highlight/detail?id=2669170175","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669170175?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:19","pubTimestamp":1790122740,"startTime":"0","endTime":"0","summary":"Prescient Therapeutics Limited ( ($AU:PTX) ) has provided an announcement. Prescient Therapeutics Limited has announced a proposed placement of up ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-plans-new-share-placement-on-asx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prescient-therapeutics-plans-new-share-placement-on-asx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669178930","title":"ZipRecruiter CEO Ian H. Siegel Disposes of $201,694.47 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2669178930","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669178930?lang=en_us&edition=fundamental","pubTime":"2026-09-23 07:24","pubTimestamp":1790119449,"startTime":"0","endTime":"0","summary":"ZipRecruiter CEO Ian H. Siegel disposes of $201,694.47 in common sharesZipRecruiter CEO Ian H. Siegel sold 54,422 Class A common shares in open-market transactions dated Sept. 18-22, 2026.Sales prices","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL5kbG1k:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ZipRecruiter CEO Ian H. Siegel Disposes of $201,694.47 in Common Shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ZIP","BK4077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669206701","title":"Press Release: Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2669206701","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669206701?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:14","pubTimestamp":1790115240,"startTime":"0","endTime":"0","summary":"HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the \"Company\" or \"Decoy\"), today issued a correction to its press release dated September 22, 2026 announcing the Compa","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","LENZ","03160","BK4099","BK4585","BK4588","DCOY","BK4007","BK4539","TM","BK4139","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669127675","title":"Pop Culture Group Co., Ltd: Enters into Share Purchase Agreement to Sell 665,000 Class a Shares at $3.00 Per Share - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669127675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669127675?lang=en_us&edition=fundamental","pubTime":"2026-09-23 05:07","pubTimestamp":1790111220,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CPOP","BK4108","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669127522","title":"Pop Culture Group Enters Registered Direct Offering for up to 665,000 Class a Shares at US$3 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2669127522","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669127522?lang=en_us&edition=fundamental","pubTime":"2026-09-23 05:01","pubTimestamp":1790110871,"startTime":"0","endTime":"0","summary":"Pop Culture Group enters registered direct offering for up to 665,000 Class A shares at US$3 eachPop Culture Group entered a share purchase agreement for a registered direct offering of up to 665,000 Class A ordinary shares.Shares are priced at US$ 3 per share, implying gross proceeds of up to about US$ 2 million.Offering will be made under the company’s effective Form F-3 shelf registration statement .Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Pop Culture Group Co. Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 22, 2026, and is solely responsible for the information c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL7Jqtfl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPOP","BK4108","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122740","title":"Biomea Fusion Updates Timeline for BMF-650 Phase I Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122740","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122740?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:38","pubTimestamp":1790109515,"startTime":"0","endTime":"0","summary":"Biomea Fusion ( ($BMEA) ) has provided an update. On September 22, 2026, Biomea Fusion, Inc. reported an updated timeline for topline results from ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-updates-timeline-for-bmf-650-phase-i-data?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biomea-fusion-updates-timeline-for-bmf-650-phase-i-data?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669122737","title":"Biomea Fusion announces offering of common stock and warrants, no amount given","url":"https://stock-news.laohu8.com/highlight/detail?id=2669122737","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669122737?lang=en_us&edition=fundamental","pubTime":"2026-09-23 04:16","pubTimestamp":1790108172,"startTime":"0","endTime":"0","summary":"Biomea Fusion (BMEA) announced that it has commenced an underwritten public offering of shares of its common stock and, in lieu of common stock to ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-announces-offering-of-common-stock-and-warrants-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-announces-offering-of-common-stock-and-warrants-no-amount-given-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4539","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":39,"pageCount":30,"totalSize":774,"code":"91000000","status":"200"}]}}